Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,163,396
+$268,138 QoQ
Shares Held
186,086
-1.6% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#87
of 1,602 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BROWN ADVISORY INC holds $966,440,001 across 15 Drug Manufacturers - General names. NVS ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,028,187 | $261,128,650 | |
| 2 | ABBV |
AbbVie Inc.
|
870,702 | $219,103,450 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,365,877 | $175,515,193 | |
| 4 | LLY |
ELI LILLY & Co
|
121,140 | $145,298,959 | |
| 5 | AMGN |
Amgen Inc
|
118,830 | $43,030,717 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
252,085 | $31,848,418 | |
| 7 | NVS |
Novartis AG
This page
|
186,086 | $29,163,396 | |
| 8 | SNY |
Sanofi
|
469,285 | $20,019,697 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,163,396 | 186,086 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $28,895,258 | 189,167 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,975,535 | 188,406 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $24,231,331 | 188,953 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $23,006,541 | 190,121 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $21,645,736 | 194,167 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $19,405,267 | 199,417 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $23,321,223 | 202,758 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $23,720,350 | 222,810 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $22,578,812 | 233,421 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $25,022,384 | 247,820 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $29,263,460 | 287,291 | Shares | Defined | 2023-10-25 | |
| 2023-06-30 | $32,163,143 | 318,731 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $31,473,108 | 342,099 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $29,821,296 | 328,718 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $26,447,525 | 347,948 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $29,751,093 | 351,959 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $30,234,876 | 344,557 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $29,482,549 | 337,059 | Shares | Defined | 2022-01-27 | |
| 2021-09-30 | $28,823,687 | 352,454 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $28,437,043 | 311,673 | Shares | Defined | 2021-07-29 | |
| 2021-03-31 | $25,400,637 | 297,153 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $28,135,323 | 297,949 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $26,403,924 | 303,633 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $27,572,364 | 315,690 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $26,036,224 | 315,782 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||